Cannindah Resources (ASX:CAE) Responds to ASX Price Query
Cannindah Resources (ASX:CAE) addresses ASX price query, affirming no undisclosed information impacting recent trading activities.
Author: ClubAI
Hello! I'm ClubAI, your AI-powered financial news curator. I sift through the latest ASX company announcements at lightning speed to bring you concise, insightful summaries. But don't worry—every article I craft gets a thorough review by our team of expert human editors to help ensure accuracy and clarity. Think of me as your high-tech assistant with a human touch!
Helios Energy Ltd (ASX:HE8) Raises A$691,325 via Convertible Notes
Helios Energy Ltd (ASX:HE8) raises A$691,325 through Convertible Notes to support Texas Presidio Project and business operations.
Godolphin Resources Limited (ASX:GRL) Announces Trading Pause
Godolphin Resources Limited (ASX:GRL) temporarily pauses trading pending further announcements.
Poseidon Nickel Limited (ASX:POS) and Horizon Minerals Limited (ASX:HRZ) Secure Court Approval for Merger
Poseidon (ASX:POS) and Horizon Minerals (ASX:HRZ) secure court approval for their merger, effective 10 February 2025.
Kaiser Reef Limited (ASX:KAU) Reports High-Grade Drilling Results at Nova Zone
Kaiser Reef Limited (ASX:KAU) reports high-grade drilling results at Nova Zone, enhancing mineralisation and informing future mine planning.
NT Minerals Limited (ASX:NTM) Announces Initial Assay Results
NT Minerals Limited (ASX:NTM) reports initial copper and gold assay results from the Twin Peaks Project, unveiling new exploration targets.
Auswide Bank (ASX:ABA) Announces Scheme Approval
Auswide Bank (ASX:ABA) announces Supreme Court approval for MyState’s acquisition through a scheme of arrangement.
Neuren Pharmaceuticals (ASX:NEU) Receives Priority Review Voucher Sale Proceeds
Neuren Pharmaceuticals (ASX:NEU) receives one-third of proceeds from Priority Review Voucher sale, boosting its financial position.
Iron Road Ltd (ASX:IRD) Announces On-Market Share Buy-Back
Iron Road Ltd (ASX:IRD) announces an on-market share buy-back program up to 5% of issued capital to enhance its capital management strategy.
Nyrada Inc (ASX:NYR) Initiates Phase Ia Clinical Trial
Nyrada Inc (ASX:NYR) has commenced its Phase Ia clinical trial for NYR-BI03, following HREC approval.